PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.95%
Revenue growth above 1.5x 3141.T's 1.45%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
9.53%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
43.67%
Positive EBIT growth while 3141.T is negative. John Neff might see a substantial edge in operational management.
30.10%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
42.72%
Positive net income growth while 3141.T is negative. John Neff might see a big relative performance advantage.
42.72%
Positive EPS growth while 3141.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
42.72%
Positive diluted EPS growth while 3141.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 3141.T is at 0.07%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3141.T is at 0.07%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.78%
10Y revenue/share CAGR under 50% of 3141.T's 70.76%. Michael Burry would suspect a lasting competitive disadvantage.
-7.65%
Negative 5Y CAGR while 3141.T stands at 57.65%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
35.01%
3Y revenue/share CAGR 1.25-1.5x 3141.T's 27.83%. Bruce Berkowitz might see better product or regional expansions than the competitor.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
70.39%
Below 50% of 3141.T's 157.37%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
2.81%
Below 50% of 3141.T's 14.01%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
47.84%
Positive short-term CAGR while 3141.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
28.23%
Below 50% of 3141.T's 112.53%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
68.77%
3Y equity/share CAGR 1.25-1.5x 3141.T's 61.74%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-100.00%
Cut dividends over 10 years while 3141.T stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-99.16%
Firm’s AR is declining while 3141.T shows 1.94%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.48%
Inventory is declining while 3141.T stands at 7.34%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.44%
Asset growth at 50-75% of 3141.T's 2.69%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
5.18%
BV/share growth above 1.5x 3141.T's 1.66%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-25.72%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
101.71%
SG&A growth well above 3141.T's 40.35%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.